Andrew J. Klein

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Temporal Trends and Outcomes of Patients Undergoing Percutaneous Coronary Interventions for Cardiogenic Shock in the Setting of Acute Myocardial Infarction

Siddharth A. Wayangankar, Sripal Bangalore, Lisa A. McCoy et al. · JACC: Cardiovascular Interventions · 2016 · 250 citations

Percutaneous Coronary Intervention, Cardiogenic Shock, Cardiovascular Disease +8

Structural measures as predictors of injury in basketball players

J. PHILIP SHAMBAUGH, Andrew J. Klein · Medicine & Science in Sports & Exercise · 1991 · 176 citations

Effects of Intravenous Nesiritide on Human Coronary Vasomotor Regulation and Myocardial Oxygen Uptake

Andrew D. Michaels, Andrew J. Klein, James A. Madden et al. · Circulation · 2003 · 75 citations